HL, i agree, none of us thought we will be like this in oct 2020, when we got the data lock. I was optimistic , we will be in hundred dollars price range in five years if we succeed in the trial. The interim trial results at that time were very encouraging for me and i jumped into this investment thinking its going to be a slamdunk investment in due course.The time line is not going as we anticipated. Thats all. but the drug is still very good and moved past many checks and the company is trying its best to straighten the manufacturing issues. If MHRA is acting irresponsibly and dragging its feet, we cannot completely blame nwbo for it. I hope they have their own good reasons for it. Moreover, nobody has the ability to predict future. So please wait for the result if you have the patience and energy. It has become an individual decision at this point about how to deal with this investment. This is just my opinion only.
Bullish
Market Data 
Markets 
